| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NeuBase Therapeutics, Inc. | Officer | Employee stock option (right to buy) | 250,000 | 24 May 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NBSE | NeuBase Therapeutics, Inc. | 24 May 2021 | 1 | $0 | 4 | Officer | 25 May 2021, 16:12 |
| NBSE | NeuBase Therapeutics, Inc. | 24 May 2021 | 0 | $0 | 3 | Chief Business & Strategy Officer. Exhibit 24 - Power of Attorney | 25 May 2021, 16:10 |